The EMMY trial was a multicentre, investigator-initiated, placebo-controlled, double-blind trial, which enrolled 476 patients immediately following AMI and the first study demonstrating a significant ...
Vienna, Austria- 31 March 2025 - While everybody’s heart has an absolute chonological age (as old as that person is), hearts also have a theoretical ‘biological’ age1 that is based on how the heart ...
The golden minute of life is defined as the first minute after birth, a critical time that newborns must show independent breathing. However, over 10% of babies every year require medical ventilation ...
An AI algorithm that can diagnose heart failure using an ECG has shown promise as a screening tool in a trial in Kenya. The burden of heart failure is particularly high in sub-Saharan Africa, with ...
Too often, the first sign of cardiovascular disease may be a major event like a heart attack, stroke or cardiac arrest. Now, researchers and clinicians at Mayo Clinic are using artificial intelligence ...
Developed using data from diverse patient groups, AIRE’s advanced AI predicts heart disease risk and mortality with precision, giving clinicians tools for more targeted, long-term patient care. Study: ...
Electrocardiograms (EKGs) can help diagnose heart failure by measuring the electrical activity of the heartbeat. Doctors use EKGs alongside other tests to help assess heart failure. Heart failure ...
A team of researchers from Tsinghua University and Beijing Tsinghua Changgung Hospital has introduced a cutting-edge method to improve the interpretation of electrocardiogram (ECG) data. Their ...
An electrocardiogram, or ECG, is a standard test that records your heart’s electrical activity – offering a quick and painless way to identify irregular heart rhythms and other potential issues. But ...
HeartSciences Inc., a medical technology company based in Southlake, TX, has received a new patent from the USPTO for its AI-powered ECG technology, which enhances the estimation of echocardiography ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced a ...